Brain Tumour Research has joined with other members of One Cancer Voice, a coalition of leading cancer charities, to develop a set of frequently asked questions (FAQs) about the COVID-19 infection (more commonly known as Coronavirus) and cancer.
The coalition has liaised with the NHS and understands that the NHS will continue to provide cancer treatments as normal and, if it becomes necessary, prioritise some patients for hospital treatment. Cancer treatment plans would only be changed if there is no alternative.
Brain Tumour Research understands that the NHS has conducted extensive work on supply chains to ensure a secure supply of necessary drugs and other requirements such as the radionuclides used in some imaging tests.
The FAQs cover concerns relevant to current patients, those who have had cancer in the past and family/friends of people living with cancer.
The FAQs will be particularly relevant to members of the brain tumour community who:
- Are currently having chemotherapy, or who have received chemotherapy in the last three months.
- Are currently undergoing immunotherapy or other continuing antibody treatments for cancer.
- Are currently receiving other targeted cancer treatments which can affect the immune system.
Related reading:
If you found this story interesting or helpful, sign up to our weekly e-news and keep up to date with all the latest from Brain Tumour Research.